Associated Papers
Can Hb A1c Be Greater Than 100%? A Case of Homozygous Hemoglobin J-Iran.
Marin MJ et al.
The Journal of Applied Laboratory Medicine, 2025
Commentary on Can Hemoglobin A1c Be Greater Than 100%? A Case of Homozygous Hemoglobin J-Iran.
Geaghan SM
The Journal of Applied Laboratory Medicine, 2025
Spectrum of Beta-Thalassemia Mutations in Potential Carriers with Microcytic Hypochromic Anemia from Mazandaran and Golestan, Northern Provinces of Iran.
Mousavi SS et al.
Biomed Research International, 2024
Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.
Tamana S et al.
Elife, 2022
36453528 (PubMed )
Supplement: elife-79713-supp2.xlsx › Input-Full_dataset
Hematological and Molecular Characterization of a Novel Hb A2 Variant with Homozygous α-Thalassemia-2 in a Southern Thai Individual.
Nuinoon M et al.
Hemoglobin, 2017
Hemoglobin J-Iran (HBB c.232C>G): Interference with the assay of HbA1c.
Kurtoğlu AU et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2017
Report on Ten Years' Experience of Premarital Hemoglobinopathy Screening at a Center in Antalya, Southern Turkey.
Canatan D et al.
Hemoglobin, 2016
Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
Henderson SJ et al.
Hemoglobin, 2016
The Prevalence of Hemoglobinopathies in Young Adolescents in the Province of Muğla in Turkey: Results of a Screening Program.
Topal Y et al.
Hemoglobin, 2015
Select a paper to view details